News
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...
On Friday, the US Food and Drug Administration approved a sickle cell disease drug called Casgevy, co-developed by Vertex Pharmaceuticals and CRISPR Therapeutics. It’s the first gene editing treatment ...
Hosted on MSN
Big News in Genetics! Japanese Scientists Remove the Extra Chromosome Causing Down Syndrome
How does the CRISPR Down Syndrome breakthrough work to remove the extra chromosome 21? We are closer than ever to a world where a genetic condition affecting one in every 700 babies could be addressed ...
CRISPRgenee is a new method that combines gene silencing and cutting to improve loss-of-function studies in human cells.
This article was written for our sponsor, Innovation Road Trip. Eradication of certain diseases, increasing crop sizes, reducing pest populations — the current and future applications of CRISPR have ...
Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...
Scientists study a molecular machine that moves jumping genes in DNA, paving the way for a new gene editing tool beyond ...
News-Medical.Net on MSN
Innovative RNA editing offers hope beyond CRISPR
Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...
CRISPR Therapeutics has a partnership with Vertex over Exa-Cel, a potentially curative therapy for Sickle Cell Disease and beta thalassemia. The FDA will hold an Advisory Committee meeting before the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results